NATR (STOCKS)
Nature's Sunshine Products Inc.
$26.750000
-0.180000 (-0.67%)
Prev close: $26.930000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Other
- CEO
- Kenneth G. Romanzi
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $468.50M
- Employees
- 819
- P/E (TTM)
- 25.48
- P/B (TTM)
- 2.92
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
5
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$0.30 | $0.19 | +0.1062 | +54.80% |
|
Sep 2025 (Q3)
|
$0.36 | $0.16 | +0.1968 | +120.59% |
|
Jun 2025 (Q2)
|
$0.35 | $0.16 | +0.1868 | +114.46% |
|
Mar 2025 (Q1)
|
$0.25 | $0.17 | +0.0817 | +48.54% |
Financial Statements
| Revenues | $480.14M |
| Benefits Costs and Expenses | $450.33M |
| Cost Of Revenue | $132.42M |
| Costs And Expenses | $450.33M |
| Gross Profit | $347.72M |
| Operating Expenses | $322.98M |
| Selling, General, and Administrative Expenses | $178.39M |
| Research and Development | $1.90M |
| Other Operating Expenses | $142.69M |
| Operating Income/Loss | $24.74M |
| Income/Loss From Continuing Operations After Tax | $20.45M |
| Income/Loss From Continuing Operations Before Tax | $29.81M |
| Income Tax Expense/Benefit | $9.36M |
| Income Tax Expense/Benefit, Current | $11.63M |
| Income Tax Expense/Benefit, Deferred | -$2.27M |
| Net Income/Loss | $20.45M |
| Net Income/Loss Attributable To Noncontrolling Interest | $930.00K |
| Net Income/Loss Attributable To Parent | $19.52M |
| Net Income/Loss Available To Common Stockholders, Basic | $19.52M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $1.08 |
| Diluted Earnings Per Share | $1.06 |
| Basic Average Shares | 18,005,000 |
| Diluted Average Shares | 18,468,000 |
| Assets | $261.15M |
| Current Assets | $178.85M |
| Inventory | $68.31M |
| Other Current Assets | $110.53M |
| Noncurrent Assets | $82.30M |
| Fixed Assets | $32.92M |
| Other Non-current Assets | $49.39M |
| Liabilities | $99.59M |
| Current Liabilities | $78.54M |
| Accounts Payable | $8.02M |
| Wages | $18.51M |
| Other Current Liabilities | $52.00M |
| Noncurrent Liabilities | $21.06M |
| Equity | $161.55M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $161.55M |
| Liabilities And Equity | $261.15M |
| Net Cash Flow From Operating Activities | $35.32M |
| Net Cash Flow From Operating Activities, Continuing | $35.32M |
| Net Cash Flow From Investing Activities | -$6.48M |
| Net Cash Flow From Investing Activities, Continuing | -$6.48M |
| Net Cash Flow From Financing Activities | -$23.77M |
| Net Cash Flow From Financing Activities, Continuing | -$23.77M |
| Exchange Gains/Losses | $4.12M |
| Net Cash Flow | $9.19M |
| Net Cash Flow, Continuing | $5.07M |
| Comprehensive Income/Loss | $19.56M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $930.00K |
| Comprehensive Income/Loss Attributable To Parent | $18.63M |
| Other Comprehensive Income/Loss | -$896.00K |